Talking stocks, trading, and investing in general

[BNA/LION]

Originally Posted by BNALION

✦ Heron Therapeutics To Take Flight In 2018
✦ Heron Therapeutics, Inc. is trading above its 50 day moving average HRTX-US: December 20, 2017
✦ Heron Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Benchmark

https://seekingalpha.com/article/412...ke-flight-2018

https://finance.yahoo.com/m/dae3a15d...C-inc.-is.html

-✦- A stock to research, track and buy if the spirit moves you. Happy Investing in 2018 and may Lady Luck be by your side!

Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference
Monday, March 12, 2018, at 3:30 p.m. EST

https://www.barchart.com/story/stock...are-conference

"Candidate HTX-011 is now in phase 2 clinical trials in combination with meloxicam for emergency room nerve block, and two phase 3 studies in combination with meloxicam for post-operative pain and inflammation in bunionectomy and hernia repair. The primary endpoint is analysis of sustained relief for the first 72 hours and minimization of the need for highly addictive opioids. Heron expects to complete pivotal phase 3 studies in 1H 2018, with NDA filing expected to follow before the end of 2018. HTX-011 is the first opioid alternative for local administration into the surgical site to be granted fast-track designation by FDA to reduce postoperative pain for 72 hours. Phase 2 studies of candidate HTX-011 demonstrated superiority over placebo and standard of care (bupivacaine) in all surgical models evaluated, having significantly reduced the need for opioids following surgery for 72 hours (bunionectomy: versus placebo (p=0.011); hernia repair: versus placebo (p=0.0001), and 75 mg bupivacaine (p=0.011)). The company released phase 2 clinical trial data in January 2017 demonstrating that HTX-011 produced statistically significant reductions in pain and need for opioids following abdominoplasty through 96 hours post-surgery as well." Seeking Alpha 12/5/17

[Rb10chris]

like watching paint dry today.. Everything waiting on 3:30

[Thatguy]

Originally Posted by BNALION

Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference

Monday, March 12, 2018, at 3:30 p.m. EST



https://www.barchart.com/story/stock...are-conference



"Candidate HTX-011 is now in phase 2 clinical trials in combination with meloxicam for emergency room nerve block, and two phase 3 studies in combination with meloxicam for post-operative pain and inflammation in bunionectomy and hernia repair. The primary endpoint is analysis of sustained relief for the first 72 hours and minimization of the need for highly addictive opioids. Heron expects to complete pivotal phase 3 studies in 1H 2018, with NDA filing expected to follow before the end of 2018. HTX-011 is the first opioid alternative for local administration into the surgical site to be granted fast-track designation by FDA to reduce postoperative pain for 72 hours. Phase 2 studies of candidate HTX-011 demonstrated superiority over placebo and standard of care (bupivacaine) in all surgical models evaluated, having significantly reduced the need for opioids following surgery for 72 hours (bunionectomy: versus placebo (p=0.011); hernia repair: versus placebo (p=0.0001), and 75 mg bupivacaine (p=0.011)). The company released phase 2 clinical trial data in January 2017 demonstrating that HTX-011 produced statistically significant reductions in pain and need for opioids following abdominoplasty through 96 hours post-surgery as well." Seeking Alpha 12/5/17

Good news as I’m up over 30% already.


Sent from my iPhone using Tapatalk

[Marciano490]

My MU and SQ have been very kind lately.

[Marciano490]

Originally Posted by usood89

NTNX.

you're welcome.

This guy deserves some credit. Wish I’d bought.

[Rb10chris]

Originally Posted by Marciano490

This guy deserves some credit. Wish I’d bought.

I was waiting for this move in Dec.. got stopped out in January when it dipped before taking off.

[superdog]

Originally Posted by Marciano490

This guy deserves some credit. Wish I’d bought.

You and me both.

[Marciano490]

Originally Posted by superdog

You and me both.

Ha, seriously. Who was that guy and what did he know? Must’ve retired to the Cayman’s by now. Oh well, not sad to still be in MU and SQ.

[Swashplate]

Ok, Pick 5 stocks that you are going to build the foundation of your childs college fund out of over the next 20 years.

[mjclark32]

Originally Posted by BNALION

Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference
Monday, March 12, 2018, at 3:30 p.m. EST

https://www.barchart.com/story/stock...are-conference

"Candidate HTX-011 is now in phase 2 clinical trials in combination with meloxicam for emergency room nerve block, and two phase 3 studies in combination with meloxicam for post-operative pain and inflammation in bunionectomy and hernia repair. The primary endpoint is analysis of sustained relief for the first 72 hours and minimization of the need for highly addictive opioids. Heron expects to complete pivotal phase 3 studies in 1H 2018, with NDA filing expected to follow before the end of 2018. HTX-011 is the first opioid alternative for local administration into the surgical site to be granted fast-track designation by FDA to reduce postoperative pain for 72 hours. Phase 2 studies of candidate HTX-011 demonstrated superiority over placebo and standard of care (bupivacaine) in all surgical models evaluated, having significantly reduced the need for opioids following surgery for 72 hours (bunionectomy: versus placebo (p=0.011); hernia repair: versus placebo (p=0.0001), and 75 mg bupivacaine (p=0.011)). The company released phase 2 clinical trial data in January 2017 demonstrating that HTX-011 produced statistically significant reductions in pain and need for opioids following abdominoplasty through 96 hours post-surgery as well." Seeking Alpha 12/5/17

Up 30% on more good news! Congrats!
https://www.marketwatch.com/story/he...MW_latest_news

[BNA/LION]

Originally Posted by BNALION

9 January 2018, 10:37 AM
https://herontherapeutics.gcs-web.co...4-ebc521f83b05
More Positive News for HRTX & HTX-011.

Related News: https://finance.yahoo.com/news/want-...113907044.html

There is a lot of chatter on the investment boards about a possible buy out in Mid-2018. If the results of the latest phase3 clinical studies for HTX-011 are positive the company will look very attractive to other big pharma companies in the pain management arena... Only time will tell. Do your research and Best of Luck!

GREAT NEWS TODAY!!!

HTX-011 Postoperative Pain Program Topline Results From Phase 3 March 19, 2018.
https://herontherapeutics.gcs-web.co...4-d8f70c249deb

[kneedeep]

Big YAY!!!!!

[BNA/LION]

I like this Comment in President Trump News Conference on Omnibus Spending Bill Today!
https://www.c-span.org/video/?443026...ll-veto-threat

Please fast forward to 16:49 pay close attention to 17:50 the end of the topic is 18:07...

Maybe it is Wishful Thinking but HTX-001 is a drug that helps combat the Opioid Crisis in hospitals and will decrease the need to prescribe them after surgeries Thus combating the addiction problem in the United States and Around the World!

[tbonesteak]

What does everyone think about gold? In early November of 2016, it looked like the safe haven, that fell apart quick.

Think the timing was just off, so I parked some money in GLD today - I sold a bunch into strength yesterday & Wednesday too and am starting to build a cash reserve.

My main goals for the time being are preservation, fwiw.

[SpeedyTuomas]

What a volatile market. Not buying before autumn..seems too risky.

[Gaijin]

Originally Posted by tbonesteak

What does everyone think about gold? In early November of 2016, it looked like the safe haven, that fell apart quick.

Think the timing was just off, so I parked some money in GLD today - I sold a bunch into strength yesterday & Wednesday too and am starting to build a cash reserve.

My main goals for the time being are preservation, fwiw.

I think preservation is good right about now..

[Emptywrist]

Originally Posted by tbonesteak

What does everyone think about gold? In early November of 2016, it looked like the safe haven, that fell apart quick.

Think the timing was just off, so I parked some money in GLD today - I sold a bunch into strength yesterday & Wednesday too and am starting to build a cash reserve.

My main goals for the time being are preservation, fwiw.

Not sure how this works? I this the stock of a gold mining company or general price of gold

Sent from my ONEPLUS A3003 using Tapatalk

[77T]

Junior Gold Miners is really a little bit of a misnomer. Silver is in there by reference since many small-capitalization companies are involved in mining for gold and/or silver per the prospectus.

Regarding GLD as some asked, it’s a SPDR that I’d suggest only for active traders. It’s 5 yr chart shows as much volatility as many consumer cyclicals.




Sent from my iPhone using Tapatalk Pro

[m j b]

Just in case anyone is following along and got confused, an SPDR (S&P Depository Receipt) is an ETF. They are not different products. However, you can have an ETF that is not an SPDR. I think.

Thanks for the info on the GDXJ, 77T, I didn't realize that it was more than just gold. Nor did I know what a lousy investment it was until after I bought it.

Another reason not to believe anything you read on the Internet.

[BNA/LION]

If HRXT closes over $30 /share that is a very good sign for the stock and its upward trend. Holding on... https://finance.yahoo.com/quote/HRTX?ltr=1

https://finance.yahoo.com/news/intri...234320257.html

[Thatguy]

Originally Posted by BNA/LION

If HRXT closes over $30 /share that is a very good sign for the stock and its upward trend. Holding on... https://finance.yahoo.com/quote/HRTX?ltr=1



https://finance.yahoo.com/news/intri...234320257.html

It’s been a nice ride so far.


Sent from my iPhone using Tapatalk

[s2h904]

I just purchased some shares of CUB-like the company/lots of potential. Just needs some volume to make a nice jump in price.

[glenn_herwig]

Thought I would make a post since I haven’t made one in awhile. Yesterday I shorted SLV for an average price of $16.12. I think gold is more attractive right now and also more stable. Silver every time it’s spiked this year and past year it’s only burned investors. Also I found some really interesting low cost alternative strategy etfs that I think can really hedge a portfolio during times of market volatility and thought I would share them with you all. I will list them below.

QAI- Funds of funds aka multi strategy
QMN- Market Neutral
DYLS- Long/Short Equity
WTMF- Managed futures

Also on schwab these are all commission free. The bid and ask spread is quit disproportionate so make sure to use limit order when buying or selling them.

If anyone ever wants to talk stocks just PM me I’m always up for chatting about stocks

[tbonesteak]

Curious for thoughts on the macro picture? Yes, earnings have been strong, unemployment is low, yada yada yada, but the reaction is muted - are we near the end/peak of this cycle?

We're 3 months into this volatile period, just some consolidation, or is the market seeing something on the horizon before we have a clear view?

[glenn_herwig]

Originally Posted by tbonesteak

Curious for thoughts on the macro picture? Yes, earnings have been strong, unemployment is low, yada yada yada, but the reaction is muted - are we near the end/peak of this cycle?

We're 3 months into this volatile period, just some consolidation, or is the market seeing something on the horizon before we have a clear view?

I think we are near the end of the cycle. This is only my opinion. I have shifted my allocation to a bunch of hedged etfs and commodities. I own some bitcoin and am playing the marijuana space too.

[m j b]

Hey, playing the marijuana space sounds like fun. Don't bogart that doobie, dude. LOL

Seriously though, I've been reading a bit about that inverted yield curve, and how its sending all kinds of signals. Today, with the suspension of some tariffs, that may move the market up, but I think the risk outweighs the reward right now with these mostly inflated valuations.

[returntorolex]

T is pretty cheap at 32.

[BNA/LION]

Nice Little Read Here!
HRTX...

This growth stock is set to sail. Or YACHT!

George Budwell (Heron Therapeutics): If you're looking for ways to grow your money at an unusually high rate, the mid-cap biotech Heron Therapeutics should be on your radar. After two positive late-stage trials for its experimental pain medication HTX-011 last month, the company is now set to have three products on the market within the next 12 months. As a result, Heron's top line is forecast to grow by an astounding 163% next year.

The best part about this story is that HTX-011 could end up becoming a major new tool to help replace opioid use in the acute-pain setting. If so, this experimental pain med should generate some truly eye-popping sales figures in the years ahead -- especially since most of the drug's direct competitors have already failed in clinical trials over the past two years. The bottom line is that Heron's HTX-011 and Pacira Pharmaceuticals' Exparel should end up gobbling up the lion's share of this multibillion-dollar drug market.

Beyond the biotech's improving fundamentals, there's also a strong chance that a top biopharma will soon make a play for Heron's analgesic and antiemetic portfolio. Pfizer, after all, is close to losing exclusivity for its megablockbuster pain med Lyrica, and this biopharma giant is absolutely flush with cash at the moment. When it comes to making deals, Pfizer is also known to prefer companies with either late-stage assets or drugs already on the market; Heron arguably checks all the boxes that Pfizer looks for in a midsized acquisition.

Heron is a solid growth play that's been greatly de-risked by the positive late-stage results for HTX-011 -- arguably making it worth a look by investors on the hunt for above-average returns on capital.

https://finance.yahoo.com/news/don-a...013200785.html

[fwong208]

One word....cryptos

[tbonesteak]

I bought JPM today, not far from the low - It is close to the 200 DMA, it has been down here multiple times this year and bounced every time... This is a swing trade, not a marriage, but a target of $114 is far from a stretch, IMO.